Company / Cash per Share
Quest Diagnostics Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.72
FY2025
5-year range
$2.32 / $6.41
FY2021-FY2025
Trend
-20.1%
vs FY2024
Sector context
#66 of 146
Health Care
What the data says
At $3.72, Quest Diagnostics's cash per share ranks #66 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.96 in FY2018 to $8.51 in FY2019.
Based on SEC 10-K filings.
3.72 in FY2025 with a 5-year CAGR of -14.9%.
Declined from $5.36 to $3.72 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Sector benchmark
#66 of 146 in Health CareTop 45% of 146This company $3.72 Sector average $27.73
▼
-86.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 20.1% year-over-year.
- Ranks #66 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.72 | -20.1% |
| FY2024 | $4.65 | -13.2% |
| FY2023 | $5.36 | +131.4% |
| FY2022 | $2.32 | -63.9% |
| FY2021 | $6.41 | -23.0% |
| FY2020 | $8.33 | -2.2% |
| FY2019 | $8.51 | +782.5% |
| FY2018 | $0.96 | -61.0% |
| FY2017 | $2.48 | +87.0% |
| FY2016 | $1.32 | +8.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026